• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 1
  3. Authors

Online ISSN: 2515-8260

Volume8, Issue1

Molecular Targeting Of Breast Cancer Stem Cells: A Promising Strategy For Management And Eradication.

    Muhammad Alaa Eldeen Amal Hashim Refaat A. Eid Nermin Raafat Nahla Alshaer

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 1, Pages 1756-1768

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

In spite of developments in breast tumors management therapeutic approaches, relapsing, metastasis and resisitant are highly observed among the patients, consequently, reduced overall survival. previously, considerable attention has been placed on the intrinsic subtyping depended in the existence or absence of traditional immunohistochemistry (IHC) markers for example estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-related protein (HER2). However, it is extensively understood that cancers are consisted of heterogeneous populations of cells with a hierarchical organization established by cancer stem cells (CSCs). In breast cancers, this CSCs displaying stem cell characteristics is identified as breast CSCs (BCSCs). This small population display a CD44+/CD24−/low phenotype with high ALDH activity (ALDH+ ), and owns advanced tolerability to chemotherapy, other cancer therapeutic approaches and has the capability of tumor bulk reproduction after reduction of cell populations sensitive to first-line therapy which leads to cancer recurrence. In this review, we present special consideration to BCSCs with future guidelines in the creation of a targeted therapy for this population.
Keywords:
    cancer stem cell chemoresistance epithelial–mesenchymal transition radioresistance therapeutic implication
  • PDF (647 K)
  • XML
(2021). Molecular Targeting Of Breast Cancer Stem Cells: A Promising Strategy For Management And Eradication.. European Journal of Molecular & Clinical Medicine, 8(1), 1756-1768.
Muhammad Alaa Eldeen; Amal Hashim; Refaat A. Eid; Nermin Raafat; Nahla Alshaer. "Molecular Targeting Of Breast Cancer Stem Cells: A Promising Strategy For Management And Eradication.". European Journal of Molecular & Clinical Medicine, 8, 1, 2021, 1756-1768.
(2021). 'Molecular Targeting Of Breast Cancer Stem Cells: A Promising Strategy For Management And Eradication.', European Journal of Molecular & Clinical Medicine, 8(1), pp. 1756-1768.
Molecular Targeting Of Breast Cancer Stem Cells: A Promising Strategy For Management And Eradication.. European Journal of Molecular & Clinical Medicine, 2021; 8(1): 1756-1768.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 118
  • PDF Download: 219
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus